[
  {
    "ts": null,
    "headline": "CDC Ends Universal Covid Vaccine Recommendation; Moderna Skids",
    "summary": "Moderna stock toppled Friday after advisors to the CDC and Prevention ended the universal recommendation for Covid vaccines.",
    "url": "https://finnhub.io/api/news?id=c8f19364725e88c69cc3f01cb8f4c3806d771018987ff3ad960e1687f15fbe12",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758317095,
      "headline": "CDC Ends Universal Covid Vaccine Recommendation; Moderna Skids",
      "id": 136823576,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Moderna stock toppled Friday after advisors to the CDC and Prevention ended the universal recommendation for Covid vaccines.",
      "url": "https://finnhub.io/api/news?id=c8f19364725e88c69cc3f01cb8f4c3806d771018987ff3ad960e1687f15fbe12"
    }
  },
  {
    "ts": null,
    "headline": "US Weighs Trump-Branded Website to Help Shop for Cheaper Drugs",
    "summary": "The initiative is part of Trump’s demands that drugmakers reduce their prices to align them with what other developed countries pay, according to the people, who spoke on condition of anonymity to discuss plans that are not yet public.  The proposed website would allow patients to search for specific medicines and be connected with platforms that sell them, the people said.",
    "url": "https://finnhub.io/api/news?id=0e750c560c0ea09bf3dc6730b90444afd04249631e5b78e5380f5bdb5e0db388",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758314575,
      "headline": "US Weighs Trump-Branded Website to Help Shop for Cheaper Drugs",
      "id": 136823430,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "The initiative is part of Trump’s demands that drugmakers reduce their prices to align them with what other developed countries pay, according to the people, who spoke on condition of anonymity to discuss plans that are not yet public.  The proposed website would allow patients to search for specific medicines and be connected with platforms that sell them, the people said.",
      "url": "https://finnhub.io/api/news?id=0e750c560c0ea09bf3dc6730b90444afd04249631e5b78e5380f5bdb5e0db388"
    }
  },
  {
    "ts": null,
    "headline": "PFE vs. AZN: Which Cancer-Focused Drug Giant Is the Better Pick?",
    "summary": "AstraZeneca and Pfizer both boast strong oncology pipelines, but growth paths, dividends and challenges set them apart for investors.",
    "url": "https://finnhub.io/api/news?id=5c1347233774fbc14134737b6c6fcb7a39f5f86f87bcf0ae3b8679862d45d732",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758288540,
      "headline": "PFE vs. AZN: Which Cancer-Focused Drug Giant Is the Better Pick?",
      "id": 136818425,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "AstraZeneca and Pfizer both boast strong oncology pipelines, but growth paths, dividends and challenges set them apart for investors.",
      "url": "https://finnhub.io/api/news?id=5c1347233774fbc14134737b6c6fcb7a39f5f86f87bcf0ae3b8679862d45d732"
    }
  },
  {
    "ts": null,
    "headline": "Arvinas reboots, cuts more staff; Porges joins Lazard",
    "summary": "Pfizer and Arvinas plan to out-license their partnered drug vepdegestrant. Elsewhere, Novo shared more data for oral Wegovy and Vertex reached a deal in Italy for coverage of its gene editing medicine Casgevy.",
    "url": "https://finnhub.io/api/news?id=2a1cb1449022cead7cf7fe93a8d58116b1e362f699d68ca7725285eae9a45abe",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758283560,
      "headline": "Arvinas reboots, cuts more staff; Porges joins Lazard",
      "id": 136820040,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Pfizer and Arvinas plan to out-license their partnered drug vepdegestrant. Elsewhere, Novo shared more data for oral Wegovy and Vertex reached a deal in Italy for coverage of its gene editing medicine Casgevy.",
      "url": "https://finnhub.io/api/news?id=2a1cb1449022cead7cf7fe93a8d58116b1e362f699d68ca7725285eae9a45abe"
    }
  },
  {
    "ts": null,
    "headline": "ISG Announces 2025 ISG Women in Digital Award Winners for EMEA",
    "summary": "LONDON, September 19, 2025--Leaders with Shell, Pfizer, BBC, Genpact, Santander and WNS have been named winners of the 2025 ISG Women in Digital Awards for EMEA.",
    "url": "https://finnhub.io/api/news?id=0f70366d4fbd83891d7f04b6fc4889e22fe218b2211799d24b37a20e279610d3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758276000,
      "headline": "ISG Announces 2025 ISG Women in Digital Award Winners for EMEA",
      "id": 136818426,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "LONDON, September 19, 2025--Leaders with Shell, Pfizer, BBC, Genpact, Santander and WNS have been named winners of the 2025 ISG Women in Digital Awards for EMEA.",
      "url": "https://finnhub.io/api/news?id=0f70366d4fbd83891d7f04b6fc4889e22fe218b2211799d24b37a20e279610d3"
    }
  },
  {
    "ts": null,
    "headline": "3 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off",
    "summary": "Everything is going great for the stock market right now. But a plot twist could be on the way.",
    "url": "https://finnhub.io/api/news?id=83fbac41b313747db68d97ddc803f962fe881723af49049708e4122c50d0141d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758275040,
      "headline": "3 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off",
      "id": 136818225,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Everything is going great for the stock market right now. But a plot twist could be on the way.",
      "url": "https://finnhub.io/api/news?id=83fbac41b313747db68d97ddc803f962fe881723af49049708e4122c50d0141d"
    }
  },
  {
    "ts": null,
    "headline": "AstraZeneca: Consistent Growth And Upcoming Catalysts Make This A Buy",
    "summary": "AstraZeneca is a leading global pharmaceutical company with strong growth in oncology, diversified revenues, and a robust pipeline. Click to read why AZN is a Buy.",
    "url": "https://finnhub.io/api/news?id=63c9970de83b73de6359dad980ea68cde4507b9840f7c6dc916a402fc1a3dead",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758274254,
      "headline": "AstraZeneca: Consistent Growth And Upcoming Catalysts Make This A Buy",
      "id": 136817825,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1250576655/image_1250576655.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "AstraZeneca is a leading global pharmaceutical company with strong growth in oncology, diversified revenues, and a robust pipeline. Click to read why AZN is a Buy.",
      "url": "https://finnhub.io/api/news?id=63c9970de83b73de6359dad980ea68cde4507b9840f7c6dc916a402fc1a3dead"
    }
  }
]